Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 433–456 of 3,236 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Metastatic Cancer, Unresectable Solid Tumor
Interventions: [18F]CSB-321; Drug
Lead sponsor: Cytosite Biopharma Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cannabis Intoxication
Interventions: 0mg THC + 0mg CBD Brownie, 10mg THC + 0mg CBD Brownie, 10mg THC + 10mg CBD Brownie, 10mg THC + 50mg CBD Brownie, 10mg THC + 100mg CBD Brownie, 10mg THC + 300mg CBD Brownie, 0mg THC + 300mg CBD Brownie; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Aging, Fall Injury Prevention, At Fall Risk
Interventions: Neck Strengthening Exercises; Other
Lead sponsor: Ohio University; Other
Eligibility: 65 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Athens, Ohio

Conditions: Colorectal Cancer
Interventions: PharmFIT; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Seattle, Washington

Conditions: Essential Tremor
Interventions: programming a, programming b; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 21 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Child Development, Parents, Prosocial and Emotional Well-Being
Interventions: ColorBRAVE; Behavioral
Lead sponsor: Tulane University; Other
Eligibility: 5 Years to 100 Years
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate, Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Biochemical Recurrence (BCR), High-Risk Localized Prostate Cancer
Interventions: RYZ711, PSMA PET/CT; Drug · Diagnostic Test
Lead sponsor: RayzeBio, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Chronic Stroke Survivors, Chronic Stroke Patients, Stroke
Interventions: Robot-assisted gait training and transcutaneous spinal cord stimulation in chronic non-ambulatory stroke survivors: pilot RCT trial, Robot assisted gait training alone; Device
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Friedreich's Ataxia
Interventions: Vatiquinone; Drug
Lead sponsor: PTC Therapeutics; Industry
Eligibility: 7 Years to 21 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 4
States / cities: Los Angeles, California • Tampa, Florida • Iowa City, Iowa + 1 more

Conditions: Glioblastoma
Interventions: Gallium Maltolate, Surgical Intervention; Drug · Procedure
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Inflammatory Bowel Disease (IBD), Colonoscopy
Interventions: Magnetic Flexible Endoscope (MFE); Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Sickle Cell Anaemia, Sickle Cell Anemia Crisis, Sickle Cell Anemia in Children, Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)
Interventions: Hemanext ONE System, Conventional RBCs; Device
Lead sponsor: Hemanext; Industry
Eligibility: 7 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 5
States / cities: Farmington, Connecticut • Atlanta, Georgia • Chicago, Illinois + 2 more

Conditions: Neuropathic Pain, Chronic Pain
Interventions: Scrambler Therapy MC-5A Device; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 5 Years to 26 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: SGLT-2 inhibitor (Sotagliflozin), Insulin withdrawal test (IWT); Drug · Other
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 18 Years to 40 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Allogenic Stem Cell Transplantation, Myeloid Malignancies, Lymphoid Malignancies, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome
Interventions: agenT-797; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Stroke
Interventions: Screener, Standard of care; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Knee Arthropathy
Interventions: Tranexamic acid (TXA), Placebo; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Preeclampsia Severe, Preeclampsia Postpartum
Interventions: Magnesium Sulfate; Drug
Lead sponsor: Alexander Harrison; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Glioma, Glioblastoma
Interventions: Cerebral open flow microperfusion; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Parkinson's Disease (PD)
Interventions: Low-fidelity driving simulator training; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 30 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Persistent HPV16 Infection
Interventions: NWRD09, Placebo; Biological
Lead sponsor: Newish Biotech (Wuxi) Co., Ltd.; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Cerebellar Stroke, Autoimmune Cerebellar Disorders
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: George Wittenberg; Other
Eligibility: 18 Years to 100 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Nutrition Poor, Nutritional Deficiency, Quality of Life
Interventions: Nutrition Algorithm; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Concussion (Diagnosis), Gait Abnormality
Interventions: Exercise, Return to Activity Progression; Behavioral
Lead sponsor: Northern Illinois University; Other
Eligibility: 18 Years to 24 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: DeKalb, Illinois

Search by objective public record fields.

CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer

Effects of Cannabidiol (CBD) on a Fixed Dose of Delta-9-tetrahydrocannabinol (THC)

Older Adult Traditional Balance Training vs Traditional Balance Training Plus Neck Strengthening

The PharmFIT Study

Image-Guided DBS Programming

Leveraging Families to Promote Healthy Socio-Emotional Development in Children

RYZ711 Diagnostic Platform Study

Walking and tSCS in Non-ambulatory Stroke Survivors

Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)

Oral Gallium Maltolate for Recurrent Glioblastoma

Visualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE) in Participants With Inflammatory Bowel Disease (IBD)

Hypoxic Red Blood Cells in Sickle Cell Anemia

Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain

Ketone Monitoring Approaches for Diabetic Ketoacidosis Risk Mitigation in People With T1D on Adjunctive SGLT-2 Inhibitors

Allogeneic iNKT Cell Therapy (agenT-797) After SCT

Reduce Inefficiencies in Management of Spasticity

Extended Oral Tranexamic Acid After Primary Total Knee Arthroplasty

Biomarkers in Management of Post Partum Preeclampsia

A Study for Cerebral Open Flow Microperfusion

Low-Fidelity Driving Simulator Training in Parkinson's Disease.

Evaluation of NWRD09 for Female Participants With Persistent HPV16 Infection

Brain Stimulation to Improvement After Cerebellar Damage

Development and Testing of Nutritional Algorithms (NACHO)

Supplementary Neuromuscular Rehabilitation During Acute Concussion Recovery